Cargando…

Tumor mutation burden-related long non-coding RNAs is predictor for prognosis and immune response in pancreatic cancer

BACKGROUND: Pancreatic cancer is one of the most common malignant tumors with extremely poor prognosis. It is urgent to identify promising prognostic biomarkers for pancreatic cancer. METHODS: A total of 266 patients with pancreatic adenocarcinoma (PAAD) in the Cancer Genome Atlas (TCGA)-PAAD cohort...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Chunjing, Wang, Zhen, Zhao, Yue, Jia, Ruichun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9710014/ https://www.ncbi.nlm.nih.gov/pubmed/36451085 http://dx.doi.org/10.1186/s12876-022-02535-z

Ejemplares similares

Role of tumor mutation burden-related signatures in the prognosis and immune microenvironment of pancreatic ductal adenocarcinoma
por: Tang, Rong, et al.
Publicado: (2021)

Research progress on long non-coding RNAs and their roles as potential biomarkers for diagnosis and prognosis in pancreatic cancer
por: Wang, Yizhi, et al.
Publicado: (2020)

An immune infiltration-related long non-coding RNAs signature predicts prognosis for hepatocellular carcinoma
por: Li, Gen, et al.
Publicado: (2022)

Four Immune-Related Long Non-coding RNAs for Prognosis Prediction in Patients With Hepatocellular Carcinoma
por: Li, Muqi, et al.
Publicado: (2020)

Significance of Tumor Mutation Burden in Immune Infiltration and Prognosis in Cutaneous Melanoma
por: Kang, Kai, et al.
Publicado: (2020)

Long non-coding RNAs in hematopoietic regulation
por: Li, Weiqian, et al.
Publicado: (2018)

Identification of N6-Methyladenosine-Associated Long Non-coding RNAs for Immunotherapeutic Response and Prognosis in Patients With Pancreatic Cancer
por: Yu, Xinshuang, et al.
Publicado: (2021)

The Role of Long Non-Coding RNAs in the Tumor Immune Microenvironment
por: Guo, Yingli, et al.
Publicado: (2022)

Mutations in lysine methyltransferase 2C and PEG3 are associated with tumor mutation burden, prognosis, and antitumor immunity in pancreatic adenocarcinoma patients
por: Huang, Yili, et al.
Publicado: (2022)

A novel immune-related long non-coding RNAs risk model for prognosis assessment of lung adenocarcinoma
por: Lu, Songmei, et al.
Publicado: (2021)

Editorial: Long Non-coding RNAs and Immunity
por: Kwon, Grace J., et al.
Publicado: (2019)

Correlation of tumor mutational burden with prognosis and immune infiltration in lung adenocarcinoma
por: Li, Lin, et al.
Publicado: (2023)

Long Non-Coding RNAs and Metabolic Rewiring in Pancreatic Cancer
por: Dalmasso, Bruna, et al.
Publicado: (2023)

Smoking status combined with tumor mutational burden as a prognosis predictor for combination immune checkpoint inhibitor therapy in non‐small cell lung cancer
por: Sun, Li‐Yue, et al.
Publicado: (2021)

Construction of a cancer-associated fibroblasts-related long non-coding RNA signature to predict prognosis and immune landscape in pancreatic adenocarcinoma
por: Ye, Yingquan, et al.
Publicado: (2022)

Association of RYR2 Mutation With Tumor Mutation Burden, Prognosis, and Antitumor Immunity in Patients With Esophageal Adenocarcinoma
por: Liu, Zaoqu, et al.
Publicado: (2021)

Identification of m(6)A-related long non-coding RNAs for predicting prognosis and immune characterizations in gastric cancer
por: Zhang, Xianhui, et al.
Publicado: (2022)

DNA Repair Gene Mutations as Predictors of Immune Checkpoint Inhibitor Response beyond Tumor Mutation Burden
por: Hsiehchen, David, et al.
Publicado: (2020)

Long Non-coding RNAs in Cancer: Implications for Diagnosis, Prognosis, and Therapy
por: Qian, Yuchen, et al.
Publicado: (2020)

Characterization of Immune-Related Long Non-coding RNAs to Construct a Novel Signature and Predict the Prognosis and Immune Landscape of Soft Tissue Sarcoma
por: Lin, Zhengjun, et al.
Publicado: (2021)

Significance of Tumor Mutation Burden Combined With Immune Infiltrates in the Progression and Prognosis of Advanced Gastric Cancer
por: Guo, Xiong, et al.
Publicado: (2021)

Long Non-Coding RNAs Involved in Immune Responses
por: Imamura, Katsutoshi, et al.
Publicado: (2014)

Long Non-Coding RNAs Regulating Immunity in Insects
por: Satyavathi, Valluri, et al.
Publicado: (2017)

Long Non-Coding RNAs and the Innate Immune Response
por: Hadjicharalambous, Marina R., et al.
Publicado: (2019)

Long non-coding RNAs in the regulation of the immune response
por: Heward, James A., et al.
Publicado: (2014)

Roles of long non-coding RNAs in plant immunity
por: Huang, Juan, et al.
Publicado: (2023)

CSMD1 Mutations Are Associated with Increased Mutational Burden, Favorable Prognosis, and Anti-Tumor Immunity in Gastric Cancer
por: Huang, Taobi, et al.
Publicado: (2021)

Relationships of N6-Methyladenosine-Related Long Non-Coding RNAs With Tumor Immune Microenvironment and Clinical Prognosis in Lung Adenocarcinoma
por: Zhao, Jianhui, et al.
Publicado: (2021)

The DNA methylation profile of non-coding RNAs improves prognosis prediction for pancreatic adenocarcinoma
por: Zhang, Jie, et al.
Publicado: (2019)

Functional implications of long non-coding RNAs in the pancreatic islets of Langerhans
por: Esguerra, Jonathan L. S., et al.
Publicado: (2014)

Long Non-Coding RNAs in Epithelial-Mesenchymal Transition of Pancreatic Cancer
por: Takahashi, Kenji, et al.
Publicado: (2021)

Identification of senescence-associated long non-coding RNAs to predict prognosis and immune microenvironment in patients with hepatocellular carcinoma
por: Gao, Chengzhi, et al.
Publicado: (2022)

A novel risk score model based on four angiogenesis long non-coding RNAs for prognosis evaluation of pancreatic adenocarcinoma
por: Cao, Guangbiao, et al.
Publicado: (2022)

A novel signature for predicting prognosis and immune landscape in cutaneous melanoma based on anoikis-related long non-coding RNAs
por: Zhang, Miao, et al.
Publicado: (2023)

Inferences of Individual Drug Response-Related Long Non-coding RNAs Based on Integrating Multi-omics Data in Breast Cancer
por: Cui, Hao, et al.
Publicado: (2020)

Genome Instability-Associated Long Non-Coding RNAs Reveal Biomarkers for Glioma Immunotherapy and Prognosis
por: Wang, Xinzhuang, et al.
Publicado: (2022)

Long Non-Coding RNAs in Pancreatic Cancer: Biologic Functions, Mechanisms, and Clinical Significance
por: Li, Jiajia, et al.
Publicado: (2022)

Long Non-coding RNAs in the Regulation of the Immune Response and Trained Immunity
por: Flores-Concha, Manuel, et al.
Publicado: (2020)

Novel tumor necrosis factor-related long non-coding RNAs signature for risk stratification and prognosis in glioblastoma
por: Long, Shengrong, et al.
Publicado: (2023)

Cuproptosis-related long non-coding RNAs model that effectively predicts prognosis in hepatocellular carcinoma
por: Huang, En-Min, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_0h1gp6c9irap6kf2ktlan32qo5